Plasma sICAM-1 correlates with tumor volume before primary radiochemotherapy of head and neck squamous cell carcinoma patients
Authors
Kerstin Clasen
Department of Radiation Oncology, Medical Faculty and University Hospital, Eberhard Karls University, Tuebingen, Germany
Stefan Welz
Department of Radiation Oncology, Marienhospital Stuttgart, Stuttgart, Germany
Heidrun Faltin
Section for Experimental Radiation Oncology, Department of Radiation Oncology, Medical Faculty and University Hospital, Eberhard Karls University, Tuebingen, Germany
Daniel Zips
Department of Radiation Oncology, Medical Faculty and University Hospital, Eberhard Karls University, Tuebingen, Germany
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) partner site Tuebingen, Tuebingen, Germany
Franziska Eckert
franziska.eckert@meduniwien.ac.at
Department of Radiation Oncology, Medical Faculty and University Hospital, Eberhard Karls University, Tuebingen, Germany
Section for Experimental Radiation Oncology, Department of Radiation Oncology, Medical Faculty and University Hospital, Eberhard Karls University, Tuebingen, Germany
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) partner site Tuebingen, Tuebingen, Germany
Department of Radiation Oncology, Medical University Vienna, AKH, Comprehensive Cancer Center, Vienna, Austria
Language: English
Page range: 501 - 507
Submitted on: Aug 31, 2022
Accepted on: Sep 29, 2022
Published on: Dec 13, 2022
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2022 Kerstin Clasen, Stefan Welz, Heidrun Faltin, Daniel Zips, Franziska Eckert, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.